Digestive comfort
One single-centre randomised trial reported a large improvement in symptoms and intestinal permeability in post-infectious irritable bowel syndrome with 15 g/day over eight weeks. It is a striking result from one site that has not been independently replicated, which is exactly the situation where enthusiasm usually runs ahead of the evidence.
What may be going on: Glutamine is the primary respiratory fuel of enterocytes and supports expression of tight junction proteins in laboratory models.
Limited evidence. Early human work, or mostly lab and animal research.
View the 3 sources
- Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome.(opens in a new tab)
Randomised controlled trial · Gut · 2019 · PMID 30108163
- A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease.(opens in a new tab)
Randomised controlled trial · The New England journal of medicine · 2021 · PMID 34192430
- Glutamine in Alleviation of Radiation-Induced Severe Oral Mucositis: A Meta-Analysis.(opens in a new tab)
Meta-analysis · Nutrition and cancer · 2016 · PMID 27045857
Deep research mode adds each paper’s own conclusion and stated limitations.